Status:
UNKNOWN
Different Positive Pressure Strategies in COPD Patients.
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is characterized by a poorly reversible airway obstruction and consequent systemic manifestations. Its high prevalence and high number of diagnosed patient...
Eligibility Criteria
Inclusion
- Patients with stage II (moderate) and III (severe) COPD according to the guidelines of the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Exclusion
- unable to understand or perform procedures that present rheumatic or orthopedic diseases or deformities / abnormalities in the spine that compromise the mechanics of the respiratory system; respiratory comorbidities such as asthma, bronchiectasis and sequela of tuberculosis, cardiovascular and neurological comorbidities; hemodynamic instability defined as heart rate greater than 150 bpm, or systolic pressure less than 90 mmHg; hypertension (blood pressure\> 149/89 mmHg) or hypotension (blood pressure \<90/60 mmHg) at the time of collection; pregnancy or suspected pregnancy; and any contraindications for the use of PEP.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03382197
Start Date
January 1 2018
End Date
November 1 2018
Last Update
July 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Therapy, Federal University of Pernambuco, Recife, Pernambuco, Brazil
Recife, Pernambuco, Brazil, 50670-901